Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2687-2695

  Wu, Hong Ge ^a   Zhang, Wen Jie ^b   Ding, Qian ^a   Peng, Gang ^a   Zou, Zhen Wei ^a   Liu, Ting ^a   Cao, Ru Bo ^a   Fei, Shi Jiang ^a   Li, Peng Cheng ^a   Yang, Kun Yu ^a   Hu, Jian Li ^a   Dai, Xiang Fang ^a   Wu, Gang ^a   Li, Pin Dong ^a  

^a UNION HOSPITAL   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

Expression; Hepatocellular carcinoma; PAQR3; Prognosis; Tumor suppressor

Indexed keywords

ALPHA FETOPROTEIN; PROGESTIN AND ADIPOQ RECEPTOR FAMILY MEMBER III; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; MEMBRANE PROTEIN; RKTG PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MITOSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEP G2 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 84914704228     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3532     Document Type: Article

References (16)

1. Parkin DM, Bray F, Ferlay J, et al: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
2. He J, Gu D, Wu X, et al: Major causes of death among men and women in China. N Engl J Med 353: 1124-1134, 2005
3. Thomas MB and Zhu AX: Hepatocellular carcinoma: The need for progress. J Clin Oncol 23: 2892-2899, 2005
4. Zender L, Villanueva A, Tovar V, et al: Cancer gene discovery in hepatocellular carcinoma. J Hepatol 52: 921-929, 2010.
5. Feng L, Xie X, Ding Q, et al: Spatial regulation of Raf kinase signaling by RKTG. Proc Natl Acad Sci USA 104: 14348-14353, 2007.
6. Luo X, Feng L, Jiang X, et al: Characterization of the topology and functional domains of RKTG. Biochem J 414: 399-406, 2008.
7. Fan F, Feng L, He J, et al: RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis 29: 1157-1163, 2008.
8. Zhang Y, Jiang X, Qin X, et al: RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene 29: 5404-5415, 2010.
9. Jiang Y, Xie X, Zhang Y, et al: Regulation of G-Protein signaling by RKTG via sequestration of the G betagamma subunit to the Golgi apparatus. Mol Cell Biol 30: 78-90, 2010.
10. Wang X, Li X, Fan F, et al: PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis 33: 2228-2235, 2012.
11. Jiang Y, Xie X, Li Z, et al: Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition. Cancer Res 71: 2959-2968, 2011.
12. Xie X, Zhang Y, Jiang Y, et al: Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse. Carcinogenesis 29: 1632-1638, 2008.
13. Grabinski N, Ewald F, Hofmann BT, et al: Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepato-cellular carcinoma cells. Mol Cancer 20: e11, 2012.
14. Psyrri A, Arkadopoulos N, Vassilakopoulou M, et al: Pathways and targets in hepatocellular carcinoma. Expert Rev Anticancer Ther 12: 1347-1357, 2012.
15. Jain S, Singhal S, Lee P, et al: Molecular genetics of hepato-cellular neoplasia. Am J Transl Res 2: 105-118, 2010.
16. Guichard C, Amaddeo G, Imbeaud S, et al: Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44: 694-698, 2012.